• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$10.37 -$0.21 (-1.98%)

REAL-TIME: Last trade at

OraSure Technologies, Inc.

NASDAQ:OSUR

OraSure Technologies Announces Rapid HCV Testing Initiatives

OraSure Technologies Applauds CDC Proposed Draft Guidelines for Testing of Baby Boomers for Hepatitis C

On The Fly: Mid-Day Wrap

OraSure supports Rapid HCV testing initiatives for 1st nat'l hepatitis test day

OraSure falls 12.6%

Pre-market Movers For May 16 (TGT, GM, PEP, GE, JCP, OSUR, CLNT, ANF, HKAC)

OraSure nears breakout above $11.78, with next resistance at $12

OraQuick(R) In-Home HIV Test Receives Unanimous Positive Recommendation From FDA Advisory Committee

Pre-market Movers For May 15 (GRPN, DKS, AVP, HD, OSUR)

FDA Blood Products Advisory Committee to host a meeting

OraSure trading halted, pending news

OraSure drops sharply, support is at $8.75 pivot

OraSure Technologies' CEO Presents at Deutsche Bank AG Health Care Conference (Transcript)

Deutsche Bank to host a conference

Canaccord Genuity Maintains a 'Buy' on OraSure Technologies (OSUR); Focus on 2012 Catalysts

OraSure Technologies, Inc. (OSUR) Tops Q1 EPS by 1c; Issues Light Q2 Outlook

OraSure sees Q2 EPS (9c)-(10c), consensus (4c)

OraSure reports Q1 EPS (7c), consensus (8c)

OraSure Technologies to Present at Deutsche Bank's 37th Annual Health Care Conference

OraSure Technologies to Present at Deutsche Bank's 37th Annual Health Care Conference

OraSure Technologies Earnings Conference Call Invitation

OraSure Technologies Earnings Conference Call Invitation

RBC Capital Starts OraSure Technologies (OSUR) at Outperform

OraSure initiated with an Outperform at RBC Capital

OraSure OTC HIV test likely to be approved in Q3, says JMP Securities

Orasure Technologies (OSUR): Advisory Committee To Review Orasure OTC Rapid HIV Test On May 15

FDA Sets Date for Advisory Committee Review of OraSure Over-the-Counter Rapid HIV Test

Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Meeting Confirms Urgent Need for Rapid Testing

Complete Genomics says DNA from saliva now accepted for sequencing

OraSure Technologies to Present at the 11th Annual Needham Healthcare Conference

JMP Securities Starts OraSure Technologies (OSUR) at Market Outperform

OraSure initiated with an Outperform at JMP Securities

McNicoll Lewis & Vlak Upgrades OraSure Technologies (OSUR) to Buy

Canaccord Genuity Reiterates a 'Buy' on OraSure (OSUR); Congress Shows Support

OraSure weakness creates buying opportunity, says ThinkEquity

OraSure Technologies to Present at the Cowen & Co. 32nd Annual Health Care Conference

A Forward Look, the Year Ahead - Featured Research on OraSure Technologies, Inc. and Thermo Fisher Scientific Inc.

OraSure Technologies to Present at the 2012 RBC Capital Markets' Healthcare Conference

OraSure Technologies to Present at the 2012 RBC Capital Markets' Healthcare Conference

Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Meeting With Management

See More Articles...